首页> 外文期刊>Digestive endoscopy: official journal of the Japan Gastroenterological Endoscopy Society >Prospective, randomized, placebo-controlled trial evaluating the efficacy and safety of propofol sedation by anesthesiologists and gastroenterologist-led teams using computer-assisted personalized sedation during upper and lower gastrointestinal endoscopy
【24h】

Prospective, randomized, placebo-controlled trial evaluating the efficacy and safety of propofol sedation by anesthesiologists and gastroenterologist-led teams using computer-assisted personalized sedation during upper and lower gastrointestinal endoscopy

机译:前瞻性,随机,安慰剂对照试验,评估麻醉师和胃肠病专家领导的小组在上,下消化道内窥镜检查过程中使用计算机辅助的个性化镇静术对丙泊酚镇静的有效性和安全性

获取原文
获取原文并翻译 | 示例
           

摘要

Background and Aim: No randomized controlled studies comparing propofol versus no sedation have been reported. Comparative data demonstrating the efficacy and safety of propofol sedation by anesthesiologists (ANES), and gastroenterologist-led teams (GLT) using computer-assisted personalized sedation (CAPS), during routine gastrointestinal (GI) endoscopy in Japan do not exist. We aimed to demonstrate the safety and efficacy of propofol sedation versus no sedation (PLCB) when propofol is given by ANES or GLT, during routine GI endoscopy.
机译:背景与目的:没有关于比较异丙酚和镇静剂的随机对照研究的报道。在日本,常规胃肠道(GI)内窥镜检查期间,尚无比较数据证明麻醉师(ANES)和胃肠病专家领导的小组(GLT)使用计算机辅助个性化镇静剂(CAPS)进行丙泊酚镇静的有效性和安全性。我们的目的是证明在常规胃肠道内窥镜检查中,当通过ANES或GLT给予丙泊酚时,与无镇静(PLCB)相比,丙泊酚镇静的安全性和有效性。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号